European Leukemia Trial Registry
Trial: AML CP4055

More Details
Title A Phase I/II Study of CP-4055 in Patients With Refractory/Relapsed Hematologic Malignancies
Scientific Title A Phase I/II Study of CP-4055 in Patients With Refractory/Relapsed Hematologic Malignancies
Short Title AML CP4055
Trialgroup NN
Type of Trial open-label
Disease Acute myeloic leukemia(AML) AML all subtypes without FAB M3
Age >= 18 years
Status Active
Start of Recruitment 01.05.2006
Contactperson

General Contact Person
Vey, Dr. med., Nobert
Tel: +33 (0)431 223695
Email: veyn@marseille.fnclcc.fr

Shortprotocol Shortprotocol
created 11.10.2007 Deniz Gökbuget
changed 23.03.2010 Irene Gleske
© 2006 ELIC European Leukemia Information Center (Dr. N. Gökbuget, Dr. S. Schäfer) | no responsibility is taken for correctness and completeness of this information | www.leukemia-net.org | elic@leukemia-net.org